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A 33-year-old, gravida 2, para 0, woman was referred
to the hospital because of intrauterine fetal death at
19 weeks’ gestation. Her pregnancy was uneventful
until that point when ultrasonography revealed a dead
fetus with cystic hygroma and a fetal biometry equivalent
to 17 weeks’ gestation. The pregnancy was terminated.
A dead 300-g fetus with cystic hygroma, holo-
prosencephaly (HPE), a single orbit and cyclopia was
delivered (Figure 1). Neither facial cleft nor polydactyly
was present. Postnatal cytogenetic analysis of placental
tissue following long-term culture showed a 47,XY,
+13[17]/46,XY[23] karyotype. Seventeen out of 40
cultured chorionic villus cells (42.5%) had an abnor-
mal 47,XY, + 13 karyotype, while 23 cells (57.5%) had 
a normal 46,XY karyotype. Molecular analysis of 
fetal and placental tissues confirmed true mosaic 
trisomy 13.
DNA was isolated from uncultured fetal skin and
placental tissue. Quantitative fluorescence polymerase
chain reaction assays and polymorphic short tandem
repeat markers for chromosome 13 were used for
determination of aneuploidy. Mosaic trisomy 13 was
evident in fetal skin and placenta. The specimens of
fetal skin and placenta showed a diallelic pattern with a
dosage ratio of 1:1.26 and 1:1.31, respectively, for the
chromosome 13-specific markers (Figure 2).
Complete trisomy 13 is well known to be associated
with major structural abnormalities such as brachy-
cephaly, microcephaly, HPE, Dandy-Walker complex,
posterior fossa abnormalities, enlarged cisterna magna,
ventriculomegaly, neural tube defects, congenital heart
defects, facial cleft, micrognathia, cystic hygroma,
nuchal edema, hydrops fetalis, omphalocele, diaphrag-
matic hernia, urinary tract abnormalities, abnormal
extremities, and polydactyly. Trisomy 13 mosaicism
displays phenotypic variability, and some of the more
characteristic physical findings observed in complete
trisomy 13, such as HPE and omphalocele, are rarely 
reported in cases with trisomy 13 mosaicism [1]. In a 
literature review of 49 published cases with trisomy 13
mosaicism, Griffith et al [1] found only three patients
with HPE [2–4] and only one with omphalocele [5].
However, congenital heart defects, facial cleft, seizures,
polydactyly, micrognathia, a short neck and ear anom-
alies are common in patients with trisomy 13
mosaicism [1].
The present case is the fourth reported case of tri-
somy 13 mosaicism associated with HPE. Wilson and
Melnyk [2] first reported mosaic translocation trisomy
13 in an infant with HPE and premaxillary agenesis,
with the translocation detected in 30% of blood lym-
phocytes. Toledo and Wajntal [3] reported mosaic tri-
somy 13 in an infant with HPE, premaxillary agenesis,
microcephaly, profound mental retardation and
growth failure, with trisomy 13 in 15.4% of blood lym-
phocytes. Lorch et al [4] reported mosaic trisomy 13 in
an infant with cebocephaly and a 10% mosaicism of
trisomy 13. Trisomy 13 accounts for up to 75% of chro-
mosomal abnormalities associated with HPE [6]. In a
meta-analysis of 132 fetuses with prenatally detected
HPE, Snijders et al [7] reported chromosomal abnor-
malities in 33% of the cases, including trisomy 13 
(n = 30), trisomy 18 (n = 7) and other rearrangements
(n = 7).
The present case is the first reported case of trisomy
13 mosaicism associated with cystic hygroma. About
75% of fetuses with cystic hygroma in the second
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Figure 1. (A, B) A malformed, macerated fetus at 19 weeks’ gestation with trisomy 13 mosaicism, cyclopia, a single
orbit, and cystic hygroma.
trimester are associated with chromosomal abnormal-
ities, and Turner syndrome accounts for 80% of these
cases [8]. The rate of chromosomal abnormalities
associated with cystic hygroma in the first trimester
appears to be lower (about 50–60%), and the occur-
rence of autosomal trisomies appears to be more com-
mon (about 60–70%) than in the second trimester.
Johnson et al [9] reported chromosomal abnormali-
ties in 60.3% (41/68) of fetuses with first-trimester
cystic hygroma, including trisomy 21 (n = 16), trisomy
18 (n = 9), trisomy 13 (n = 2), 45,X (n = 9) and other
rearrangements (n = 5). Trauffer et al [10] reported
chromosomal abnormalities in 48.8% (21/43) of
fetuses with first-trimester cystic hygroma, including
trisomy 21 (n =9), trisomy 18 (n =4), trisomy 13 (n =1),
Turner syndrome (n = 4) and translocations (n = 3).
Malone et al [11] reported chromosomal abnormali-
ties in 50.8% (67/132) of fetuses with first-trimester
septated cystic hygroma, including trisomy 21 (n = 25),
Turner syndrome (n = 19), trisomy 18 (n = 13), trisomy
13 (n = 6), triploidy (n = 3) and mosaic deletion of
chromosome 9 (n = 1). Kharrat et al [12] reported
chromosomal abnormalities in 59.5% (25/42) of
fetuses with first-trimester cystic hygroma, including
trisomy 18 (n = 10), trisomy 13 (n = 6) and 45,X (n = 9).
Graesslin et al [13] reported chromosomal abnormali-
ties in 52.8% (38/72) of fetuses with first-trimester
cystic hygroma, including trisomy 21 (n = 14), trisomy
18 (n = 7), trisomy 13 (n = 3), Turner syndrome (n = 11)
and other rearrangements (n = 3). In a meta-analysis,
Molina et al [14] found chromosomal abnormalities
in 53.1% (139/262) of fetuses with first-trimester cystic
hygroma, including trisomies 21, 18 and 13 (n = 84),
Turner syndrome (n = 42) and other rearrangements
(n = 13).
Counseling parents of a child with trisomy 13
mosaicism remains difficult because of the phenotypic
variability associated with the condition; some
patients have a typical phenotype of complete trisomy
13 with neonatal death, while others have few dysmor-
phic features and prolonged survival [1,15,16]. We
have presented an unusual case of trisomy 13
mosaicism associated with concomitant cyclopia and
cystic hygroma. Perinatal identification of concomi-
tant HPE and cystic hygroma should prompt cytogenetic
analysis to rule out chromosomal abnormalities. As
demonstrated in this case, placental tissue is a valuable
source of material for cytogenetic analysis of mal-
formed fetuses following intrauterine fetal death.
Quantitative fluorescence polymerase chain reaction
provides a powerful tool for rapid tissue confirmation
of true chromosomal mosaicism.
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Figure 2. Representative electrophoretogram of quantitative
fluorescence polymerase chain reaction assays for short tan-
dem repeat markers for chromosome 13, using fetal skin and
placenta. With the microsatellite marker D13S765, two
peaks (191 and 203 bp) of unequal fluorescence activity with
ratios of 1:1.26 and 1:1.31 were seen in the specimens of fetal
skin and placenta, respectively.
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